Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | Key updates from EORTC CL 2021

Jan P. Nicolay • 15 Oct 2021
EORTC CLTF 2021
B-Cell Lymphoma Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases
PROCLIPI

Jan P. Nicolay, MD, Ruprecht Karls University of Heidelberg, Mannheim, Germany, gives an overview of key updates presented at the EORT CLTF 2021 meeting, highlighting data from the Prospective Cutaneous Lymphoma International Prognostic Indices (PROCLIPI) study, and the identification of novel relevant pathways in cutaneous T-cell lymphoma (CTCL) and cutaneous B-cell lymphoma (CBCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Jan P. Nicolay

0:57
Novel targets in the treatment of CTCL
Jan P. Nicolay • 15 Oct 2021
1:20
DMF therapy for CTCL
Jan P. Nicolay • 15 Oct 2021
1:08
The benefits of combination approaches in CTCL
Jan P. Nicolay • 15 Oct 2021
0:50
Pre-clinical studies in CTCL
Jan P. Nicolay • 15 Oct 2021

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals